iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology

NACompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

August 31, 2019

Study Completion Date

December 31, 2020

Conditions
Atrial FibrillationAtrial Flutter
Interventions
DEVICE

AliveCor

"The AliveCor Heart Monitor, an FDA-approved smartphone technology, snaps on to the patient's study smartphone similar to a protective case and works through a free application, AliveECG. It captures a highly sensitive (98%), specific (97%), and accurate (97%) single-lead ECG recording through two electrodes on the back of the patient's smartphone. When the application is opened, recording begins automatically when both electrodes make contact with skin. Transmissions are automatically uploaded to the study patient portal within the AliveCor cloud."

BEHAVIORAL

Behavioral Altering Messaging

Behavioral altering messages relating to the participant's AF and underlying cardiac risk factors will be systematically selected from a bank of text messages developed through collaboration by the study team and an expert interdisciplinary panel from the American Heart Association. The content of the text messages will not include PHI. The final text message bank will be housed internally and maintained by the Data Manager and text messages will be pushed automatically from this database. The only identifying link to participants included in this database will be their study-provided phone number

Trial Locations (1)

10025

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT02731326 - iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology | Biotech Hunter | Biotech Hunter